English (international)
Eesti
Български
Deutsch
Français
Español (Latinoamérica)
Polski
Magyar
Română
Atrion Corp
Closed
Sector Healthcare
455.76 0.02
Overview
Share price change
24h
Min
455.41
Max
457.7
Income | 2.9M |
|---|---|
Sales | 1.7M 44M |
EPS | 3.648 |
Profit margin | 7.012 |
Employees | 712 |
EBITDA | 7.9M |
Next Earnings | 5 sie 2024 |
|---|---|
Next Dividend date | 27 wrz 2024 |
Next Ex Dividend date | 12 wrz 2024 |
Market Cap | 45M 777M |
|---|---|
Previous open | 455.74 |
Previous close | 455.76 |
News Sentiment
By Acuity
50%
50%
123 / 369 Ranking in Healthcare
Technical Score
By Trading Central
Confidence
Bullish Evidence
Atrion Corp Chart
Related News
Peer Comparison
Price change
Atrion Corp Forecast
Sentiment
By Acuity
123 / 369 Ranking in Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Atrion Corp
Atrion Corporation (Atrion) is engaged in developing and manufacturing products primarily for medical applications. The Company markets components to other equipment manufacturers for incorporation in their products and sell finished devices to physicians, hospitals, clinics and other treatment centers. Its medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. Its fluid delivery products include valves designed to fill, hold and release controlled amounts of fluids or gasses in fields, such as anesthesia and oncology. Its cardiovascular product, Myocardial Protection System (MPS3), is a technology used in the open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. Atrion also manufacture a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.
